PHARMACY PRACTICE AND THERAPEUTICS E (ONCOLOGY AND PALLIATIVE CARE)

PHA4THE

2021

Credit points: 15

Subject outline

This subject introduces the broad range of drugs used in the treatment of neoplastic diseases, as well as medicines and other treatment modalities employed in the area of palliative care to fourth year pharmacy students. These specialist areas will be covered by an overview of the pathophysiology of cancer, followed by systematic review of the major classes of antineoplastic drugs, including mechanisms of action and patient care issues. Specific issues regarding the delivery of palliative care to terminally ill patients will be explored through a series of structured lectures as well as directed learning and presentations by the students.

SchoolMolecular Sciences

Credit points15

Subject Co-ordinatorJoseph Tucci

Available to Study Abroad/Exchange StudentsNo

Subject year levelYear Level 4 - UG/Hons/1st Yr PG

Available as ElectiveNo

Learning ActivitiesN/A

Capstone subjectNo

Subject particulars

Subject rules

Prerequisites PHA3THD Only available to students admitted in the Bachelor of Pharmacy course (SHPB)

Co-requisitesPHA4PCA

Incompatible subjectsN/A

Equivalent subjectsN/A

Quota Management StrategyN/A

Quota-conditions or rulesN/A

Special conditionsN/A

Minimum credit point requirementN/A

Assumed knowledgeN/A

Readings

Therapeutic Guidelines: Neurology

Resource TypePrescribed

Resource RequirementN/A

AuthorVersion 4.

Year2011

Edition/VolumeN/A

PublisherTherapeutic Guidelines Limited

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Therapeutic Guidelines: Psychotropic.

Resource TypePrescribed

Resource RequirementN/A

AuthorVersion 7.

Year2013

Edition/VolumeN/A

PublisherTherapeutic Guidelines Limited

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Pharmacology

Resource TypePrereading

Resource RequirementN/A

AuthorRang, HP et al.

Year2011

Edition/Volume7th edition

PublisherChurchill Livingstone, Edinburgh

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Goodman & Gilman's Manual of Pharmacology and Therapeutics

Resource TypeRecommended

Resource RequirementN/A

AuthorBrunton, L & Parker, K eds.

Year2011

Edition/VolumeN/A

PublisherMcGraw-Hill

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Clinical Pharmacy and Therapeutics

Resource TypePrescribed

Resource RequirementN/A

AuthorWalker, R. and Whittlesea, C.

Year2012

Edition/VolumeN/A

PublisherChurchill Livingstone

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Therapeutic Guidelines: Analgesic

Resource TypePrescribed

Resource RequirementN/A

AuthorVersion 5.

Year2007

Edition/VolumeN/A

PublisherTherapeutic Guidelines Limited

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Australian Medicines Handbook.

Resource TypePrescribed

Resource RequirementN/A

AuthorRossi, R.

Year2017

Edition/VolumeN/A

PublisherAustralian Medicines Handbook Pty Ltd

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Therapeutic Guidelines: Palliative care.

Resource TypePrescribed

Resource RequirementN/A

AuthorVersion 3

Year2010

Edition/VolumeN/A

PublisherTherapeutic Guidelines Limited

ISBNN/A

Chapter/article titleN/A

Chapter/issueN/A

URLN/A

Other descriptionN/A

Source locationN/A

Career Ready

Career-focusedNo

Work-based learningNo

Self sourced or Uni sourcedN/A

Entire subject or partial subjectN/A

Total hours/days requiredN/A

Location of WBL activity (region)N/A

WBL addtional requirementsN/A

Graduate capabilities & intended learning outcomes

Graduate Capabilities

Intended Learning Outcomes

01. Describe and explain the pathophysiology of cancer
02. Explain the mechanisms of action and patient care issues in relation to major classes of antineoplastic drugs.
03. Describe and explain the relationship between drug actions and therapeutic outcomes, specifically in cancer related clinical conditions and also to address the important issues underlying the delivery of palliative care to terminally ill patients.
04. Describe the absorption, elimination and metabolism of these classes of drugs and relate this to clinical practice and how pharmacogenetics affects this.
05. Anticipate, and rationalise interaction between drugs (including over-the-counter (OTC preparations)
06. Undertake research on specific areas of palliative care and present the information in an instructive and clear manner
07. Work within a team to organise tasks such as researching, preparation, editing and oral presentation of information to an audience of peers.

Subject options

Select to view your study options…

Start date between: and    Key dates

Bendigo, 2021, Semester 1, Day

Overview

Online enrolmentYes

Maximum enrolment sizeN/A

Subject Instance Co-ordinatorJoseph Tucci

Class requirements

LectureWeek: 10 - 22
Three 1.00 h lecture per week on weekdays during the day from week 10 to week 22 and delivered via face-to-face.

WorkShopWeek: 11 - 22
One 2.00 h workshop per week on weekdays during the day from week 11 to week 22 and delivered via face-to-face.
Workshops are compulsory for all students. A medical certificate will be needed if a student does not attend.

Assessments

Assessment elementCommentsCategoryContributionHurdle% ILO*
One 3-hour examinationN/AN/AN/ANo60 SILO1, SILO2, SILO3, SILO4, SILO5
One 1-hour mid-semester testN/AN/AN/ANo20 SILO1, SILO2, SILO3, SILO4
One 40-minute team oral presentation (500 word equivalent/student)N/AN/AN/ANo20 SILO1, SILO5, SILO6, SILO7